• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Use of hepatocyte growth factor activator for limited digestion of tagged fusion proteins

Research Project

Project/Area Number 11557181
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section展開研究
Research Field Biological pharmacy
Research InstitutionTOKYO INSTITUTE OF TECHNOLOGY

Principal Investigator

MIYAZAWA Keiji  Tokyo Institute of Technology, Graduate School of Bioscience and Biotechnology Associate professor, 大学院・生命理工学研究科, 助教授 (40209896)

Co-Investigator(Kenkyū-buntansha) SHIMOMURA Takeshi  Mitsubishi-Tokyo Pharmaceuticals Inc, Pharmaceuticals Discovery Laboratory Senior Research Scientist, 創薬基盤研究所, 主管研究員
KITAMURA Naomi  Tokyo Institute of Technology, Graduate School of Bioscience and Biotechnology Professor, 大学院・生命理工学研究科, 教授 (80107424)
Project Period (FY) 1999 – 2000
Keywordsprotease / fusion protein / limited digestion / recombinant protein
Research Abstract

Proteases with high substrate specificity as well as high efficiency are desirable for limited digestion of tagged fusion proteins. In this project, we examined the use of hepatocyte growth factor activator (HGFA) for this purpose.
First, we introduced an HGFA-substrate peptide sequence into GST fusion protein. Anoligonucleotide coding HGFA cleavage sequence (AKTKQLRVVNG) was inserted downstream of thrombin cleavage site of pGEX4T-3 vector. For assesing the utility of this system, JNK interacting protein-1 (JIP-1) was used as a model protein for expression and cleavage. The expressed fusion protein (GST-JIP1) was treated with HGFA as well as thrombin at substrate/enzyme ratio of 50/1 at 37℃ for 4 hours. Thrombin treatment caused extensive degradation of the JIP-1 moiety of the fusion protein, whereas HGFA treatment caused cleavage of the linker peptide without extra digestion. HGFA treatment was successful for other fusion proteins, GST-NK1 (a variant of hepatocyte growth factor) and GST-Met kinase domain. This system worked in the presence of glutathione, indicating that column eluate from glutathione-Sepharose can be processed for digestion without pretreatment. The system, however, failed to work in the presence of 0.5-2M urea, indicating that urea-solubilized proteins should be devoid of urea before digestion.

  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Kataoka,H. et al.: "Hepatocyte growth factor activator inhibitor type 1 (HAI-1) Is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in pericellular microenvironment"J.Biol.Chem.. 275. 40453-40462 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kato,M. et al.: "A de-ubiquitinating enzyme UBPY interacts with the SH3 domain of Hrs binding protein via a novel binding motif Px(V/I)(D/N)RxxKP"J.Biol.Chem.. 275. 37481-37487 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Itoh,H. et al.: "Mouse hepatocyte growth factor activator gene : its expression not only in the liver but also in the gastrointestinal tract"Biochim.Biophys.Acta. 1491. 295-302 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Leppanen,O.-P. et al.: "Predimerization of recombinant platelet-derived growth factor receptor extracellular domains increases antagonistic potency"Biochemistry. 39. 2370-2375 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimomura,T. et al.: "Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form"J.Biochem.. 126. 821-828 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimomura, T., Denda, K., Kawaguchi, T., Matsumoto, K., Miyazawa, K., and Kitamura, N.: "Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form."J.Biochem.. 126. 821-828 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Leppanen, O.-P., Myazawa, K., Backstrom, G., Pietras, K., Sjoblom, T., Heldin, C.-H., and Ostman, A.: "Predimerization of recombinant platelet-derived growth factor receptor extracellular domains increases antagonistic potency."Biochemistry. 39. 2370-2375 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Itoh, H.. Hamasuna, R., Kataoka, H., Yamauchi, M., Miyazawa, K., Kitamura, N., and Koono, M.: "Mouse hepatocyte growth factor activator gene : its expression not only in the liver but also in the gastrointestinal tract."Biochim.Biophys.Acta. 1491. 295-302 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kato, M., Miyazawa, K., and Kitamura, N.: "A de-ubiquitinating enzyme UBPY interacts with the SH3 domain of Hrs binding protein via a novel binding motif Px (V/I)(D/N) RxxKP."J.Biol.Chem.. 275. 37481-37487 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kataoka, H., Shimomura, T., Kawaguchi, T., Hamasuna, R., Itoh, H., Kitamura, N., Miyazawa, K., and Koono, M.: "Hepatocyte growth factor activator inhibitor type 1 (HAI-1) Is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in pericellular microenvironment."J.Biol.Chem.. 275. 40453-40562 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi